Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...